Institut Universitaire du Cancer Toulouse - Oncopole
Toulouse, 31059, France
NCT Number: NCT05494970
Feasibility, prospective, monocentric study aiming to evaluate the interest of a written information guide, given and explained by the dental assistant, on the improvement of the oral hygiene of patients with ORL cancer at 3 months post-radiotherapy.
The study will be conducted on a population of 44 patients with ORL cancer requiring radiation treatment.
Each patient will be followed during 3 months post-radiotherapy (follow-up for up to 12 months post-inclusion).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Toulouse, 31059, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Inclusion visit (before radiotherapy treatment):
End of study visit (three months post-radiotherapy):
Time frame: 3 months per patient
Improvement is defined as a gross decrease of at least 30% in the plaque index between the inclusion visit and 3 months post-radiotherapy. The plaque index will be evaluated using the O'Leary method.
Time frame: 3 months per patient
It will be evaluated by means of a satisfaction questionnaire.
Time frame: 3 months per patient
It will be evaluated with the questionnaire "Motivation and oral hygiene behavior".
Institut Claudius Regaud
Other
Accompaniment of Patients by Dental Assistants in the Evaluation of Oral Hygiene During and After Radiotherapy Treatment: a Feasibility Study.
Acronym: RadioT HBD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06517355
ORL Cancer
Toulouse, France
View Trial DetailsNCT04940000
ORL Cancer
Toulouse, France
View Trial Details